RE: Oral Leukoplakia and Risk of Progression to Oral Cancer: A Population-Based Cohort Study.
作者信息
Brandt Burkhard H, Bednarz-Knoll Natalia, Kleinheinz Johannes, Franke Andre, Fillies Thomas
机构信息
Institute of Clinical Chemistry, University Hospital Schleswig-Holstein, Kiel, Germany.
Laboratory of Translational Oncology, Medical University of Gdańsk (formerly), Department of Medical Biotechnology, Intercollegiate Faculty of Biotechnology, Laboratory of Cell Biology, University of Gdańsk and Medical University of Gdańsk, Gdańsk, Poland.
出版信息
J Natl Cancer Inst. 2020 Sep 1;112(9):968-969. doi: 10.1093/jnci/djaa074.
Abstract
摘要
相似文献
1
RE: Oral Leukoplakia and Risk of Progression to Oral Cancer: A Population-Based Cohort Study.主题：口腔白斑与进展为口腔癌的风险：一项基于人群的队列研究。
J Natl Cancer Inst. 2020 Sep 1;112(9):968-969. doi: 10.1093/jnci/djaa074.
2
Oral Leukoplakia and Risk of Progression to Oral Cancer: A Population-Based Cohort Study.口腔白斑病与口腔癌进展风险：基于人群的队列研究。
J Natl Cancer Inst. 2020 Oct 1;112(10):1047-1054. doi: 10.1093/jnci/djz238.
3
Leukoplakia and incidence of oral cancer.白斑与口腔癌发病率
J Oral Pathol Med. 1989 Jan;18(1):17. doi: 10.1111/j.1600-0714.1989.tb00725.x.
4
Risk factors for leukoplakia and malignant transformation to oral carcinoma: a leukoplakia cohort in Taiwan.口腔白斑及恶变至口腔癌的危险因素：台湾的一个口腔白斑队列研究
Br J Cancer. 2000 Jun;82(11):1871-4. doi: 10.1054/bjoc.2000.1208.
5
[Leukoplakia of the oral mucosa].[口腔黏膜白斑病]
Orv Hetil. 1979 Nov 18;120(46):2779-81.
6
[Effect of smoking on the development of oral leukoplakia].
Fogorv Sz. 2001 Jun;94(3):91-6.
7
Quantitative prediction of oral cancer risk in patients with oral leukoplakia.口腔白斑患者口腔癌风险的定量预测
Oncotarget. 2017 Jul 11;8(28):46057-46064. doi: 10.18632/oncotarget.17550.
8
Leukoplakia, Oral Cavity Cancer Risk, and Cancer Survival in the U.S. Elderly.美国老年人的口腔白斑、口腔癌风险及癌症生存率
Cancer Prev Res (Phila). 2015 Sep;8(9):857-63. doi: 10.1158/1940-6207.CAPR-15-0091. Epub 2015 Jul 9.
9
An epidemiologic assessment of cancer risk in oral precancerous lesions in India with special reference to nodular leukoplakia.印度口腔癌前病变癌症风险的流行病学评估，特别提及结节性白斑。
Cancer. 1989 Jun 1;63(11):2247-52. doi: 10.1002/1097-0142(19890601)63:11<2247::aid-cncr2820631132>3.0.co;2-d.
10
Chemoprevention of oral leukoplakia and chronic esophagitis in an area of high incidence of oral and esophageal cancer.口腔和食管癌高发地区口腔白斑和慢性食管炎的化学预防
Ann Epidemiol. 1993 May;3(3):225-34. doi: 10.1016/1047-2797(93)90023-w.
引用本文的文献
1
Response to Brandt, Bednarz-Knoll, Kleinheinz et al.对布兰特、贝德纳兹-克诺尔、克莱因海因茨等人的回应
J Natl Cancer Inst. 2020 Sep 1;112(9):970-971. doi: 10.1093/jnci/djaa075.
本文引用的文献
1
Oral Leukoplakia and Risk of Progression to Oral Cancer: A Population-Based Cohort Study.口腔白斑病与口腔癌进展风险：基于人群的队列研究。
J Natl Cancer Inst. 2020 Oct 1;112(10):1047-1054. doi: 10.1093/jnci/djz238.
2
Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial.厄洛替尼和口腔癌风险：厄洛替尼预防口腔癌（EPOC）随机临床试验。
JAMA Oncol. 2016 Feb;2(2):209-16. doi: 10.1001/jamaoncol.2015.4364.
3
Epidermal growth factor receptor expression and gene copy number in the risk of oral cancer.表皮生长因子受体表达和基因拷贝数与口腔癌风险的关系。
Cancer Prev Res (Phila). 2010 Jul;3(7):800-9. doi: 10.1158/1940-6207.CAPR-09-0163. Epub 2010 Jun 22.
4
Pharmacogenomic and pharmacokinetic determinants of erlotinib toxicity.厄洛替尼毒性的药物基因组学和药代动力学决定因素。
J Clin Oncol. 2008 Mar 1;26(7):1119-27. doi: 10.1200/JCO.2007.13.1128.
5
Mechanisms of egfr gene transcription modulation: relationship to cancer risk and therapy response.表皮生长因子受体（EGFR）基因转录调控机制：与癌症风险及治疗反应的关系
Clin Cancer Res. 2006 Dec 15;12(24):7252-60. doi: 10.1158/1078-0432.CCR-06-0626.
6
Aberrations of erbB-1 and erbB-2 oncogenes in non-dysplastic leukoplakias of the oral cavity.
Br J Oral Maxillofac Surg. 1999 Dec;37(6):477-80. doi: 10.1054/bjom.1999.0185.
Zotero 插件